COVID-19 convalescent plasma is plasma collected from patients who have acquired and subsequently recovered from COVID-19 and which contains antibodies against the causative agent SARS-CoV-2. This investigational COVID-19 treatment is... This investigational COVID-19 treatment is currently available through three main pathways: use in registered clinical trials, use through the expanded access COVID-19 protocol (21 CFR 312.305), and use for single patients through an emergency IND...
- Mechanism
- Curator reviewed
Pharmacologically active on Spike glycoprotein
- Also known as
- anti-SARS-CoV-2 convalescent plasma · convalescent COVID-19 plasma · Convalescent plasma (COVID-19)
Resolves to
What you can answer from here — as of July 08, 2026
Which drugs share a target with COVID-19 convalescent plasma, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account